BR112012000804B8 - composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água - Google Patents
composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com águaInfo
- Publication number
- BR112012000804B8 BR112012000804B8 BR112012000804A BR112012000804A BR112012000804B8 BR 112012000804 B8 BR112012000804 B8 BR 112012000804B8 BR 112012000804 A BR112012000804 A BR 112012000804A BR 112012000804 A BR112012000804 A BR 112012000804A BR 112012000804 B8 BR112012000804 B8 BR 112012000804B8
- Authority
- BR
- Brazil
- Prior art keywords
- mixing
- water
- composition
- kit
- aqueous solution
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 3
- 239000007864 aqueous solution Substances 0.000 title 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
composições, soluções e kit para limpeza de cólon, bem como método para tal e uso de componentes para preparação de solução. a presente invenção refere-se a uma composição seca para mistura com água, onde a composição é opcionalmente apresentada em duas ou mais partes e compreende, por litro de solução a ser aplicada, os seguintes componentes: (a) 85 a 115 g de polietileno glicol (peg) tendo um peso molecular médio de 2500 a 4500; (b) 6 a 9 g de sulfato de sódio; (c) 2 a 3 g 1 o de cloreto de sódio; (d) 0,5 a 1,5 g de cloreto de potássio; (e) 5 a 15 g de um componente ácido orgânico; e (f) aromatizante laranja. também são provi- das soluções, kits, doses unitárias e processos que compreendem ou usam as composições.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0912487.6 | 2009-07-17 | ||
GBGB0912487.6A GB0912487D0 (en) | 2009-07-17 | 2009-07-17 | Improvements in and relating to colon cleansing compositions |
US30581410P | 2010-02-18 | 2010-02-18 | |
US61/305,814 | 2010-02-18 | ||
PCT/GB2010/001362 WO2011007153A1 (en) | 2009-07-17 | 2010-07-16 | Improvements in and relating to colon cleansing compositions |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012000804A2 BR112012000804A2 (pt) | 2016-02-23 |
BR112012000804B1 BR112012000804B1 (pt) | 2021-03-30 |
BR112012000804B8 true BR112012000804B8 (pt) | 2021-05-25 |
Family
ID=41058153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012000804A BR112012000804B8 (pt) | 2009-07-17 | 2010-07-16 | composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2453873B1 (pt) |
KR (2) | KR20180012866A (pt) |
AT (1) | AT13208U1 (pt) |
BR (1) | BR112012000804B8 (pt) |
CA (1) | CA2768275C (pt) |
EA (1) | EA025767B1 (pt) |
ES (1) | ES2886335T3 (pt) |
FR (1) | FR2948029A1 (pt) |
GB (2) | GB0912487D0 (pt) |
LU (1) | LU91786B1 (pt) |
NL (1) | NL2005102C2 (pt) |
NZ (1) | NZ595785A (pt) |
SG (1) | SG178044A1 (pt) |
WO (1) | WO2011007153A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012013928A1 (en) * | 2010-07-27 | 2012-02-02 | Norgine Bv | Compositions |
EA028925B1 (ru) * | 2011-01-31 | 2018-01-31 | Норджин Бв | Способ лечения констипации и/или уплотнения фекальных масс, водный раствор для лечения констипации и/или уплотнения фекальных масс, набор и лекарственное средство (варианты) |
TWI535461B (zh) * | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
PT2787982T (pt) * | 2011-12-07 | 2023-05-10 | Msm Innovations Inc | Composição para preparação intestinal |
PT2879715T (pt) | 2012-08-03 | 2023-04-26 | Msm Innovations Inc | Método e kit para preparação intestinal |
KR20210063445A (ko) * | 2012-09-11 | 2021-06-01 | 노어긴 비.브이. | Peg 및 아스코르베이트를 포함하는 조성물 |
KR20140044628A (ko) * | 2012-10-05 | 2014-04-15 | 주식회사태준제약 | 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물 |
PT2968174T (pt) | 2013-03-15 | 2020-01-15 | Braintree Laboratories Inc | Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização |
KR20190093489A (ko) | 2018-02-01 | 2019-08-09 | 주식회사태준제약 | 장세척 조성물 |
WO2019151829A1 (ko) * | 2018-02-01 | 2019-08-08 | 주식회사태준제약 | 장세척 조성물 |
RU2709495C1 (ru) * | 2019-08-01 | 2019-12-18 | Общество с ограниченной ответственностью "Гелеспон" | Способ очищения кишечника и набор для его осуществления |
TR201912004A2 (tr) * | 2019-08-07 | 2021-02-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Poli̇eti̇len gli̇kol i̇çeren bi̇r saşe formülasyonu |
CN111617102B (zh) * | 2020-05-25 | 2022-05-31 | 南京金凯木纳米材料有限公司 | 一种含聚乙二醇的电解质散剂及其制备方法 |
KR20220033790A (ko) * | 2020-09-10 | 2022-03-17 | 강윤식 | 장 정결용 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0224909D0 (en) * | 2002-10-25 | 2002-12-04 | Norgine Europe Bv | Colon cleansing compositions |
US20100297264A1 (en) * | 2007-10-17 | 2010-11-25 | Thomas Jefferson University | Bowel purgative and uses thereof |
CL2008003230A1 (es) * | 2007-11-01 | 2009-11-27 | Sanofi Aventis Healthcare Pty Ltd | Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta. |
-
2009
- 2009-07-17 GB GBGB0912487.6A patent/GB0912487D0/en not_active Ceased
-
2010
- 2010-07-16 GB GB1012038A patent/GB2471954A/en not_active Withdrawn
- 2010-07-16 KR KR1020187001789A patent/KR20180012866A/ko active Search and Examination
- 2010-07-16 ES ES10737362T patent/ES2886335T3/es active Active
- 2010-07-16 AT ATGM9007/2010U patent/AT13208U1/de not_active IP Right Cessation
- 2010-07-16 BR BR112012000804A patent/BR112012000804B8/pt active IP Right Grant
- 2010-07-16 EA EA201200153A patent/EA025767B1/ru unknown
- 2010-07-16 SG SG2012003463A patent/SG178044A1/en unknown
- 2010-07-16 EP EP10737362.3A patent/EP2453873B1/en active Active
- 2010-07-16 KR KR1020127003521A patent/KR20120070560A/ko active Application Filing
- 2010-07-16 WO PCT/GB2010/001362 patent/WO2011007153A1/en active Application Filing
- 2010-07-16 NL NL2005102A patent/NL2005102C2/en active
- 2010-07-16 LU LU91786A patent/LU91786B1/fr active
- 2010-07-16 CA CA2768275A patent/CA2768275C/en active Active
- 2010-07-16 NZ NZ595785A patent/NZ595785A/en unknown
- 2010-07-19 FR FR1055854A patent/FR2948029A1/fr active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2948029A1 (fr) | 2011-01-21 |
BR112012000804A2 (pt) | 2016-02-23 |
GB0912487D0 (en) | 2009-08-26 |
GB2471954A (en) | 2011-01-19 |
GB201012038D0 (en) | 2010-09-01 |
NZ595785A (en) | 2014-09-26 |
WO2011007153A1 (en) | 2011-01-20 |
IE20100443A1 (en) | 2011-02-16 |
WO2011007153A8 (en) | 2011-03-10 |
EP2453873A1 (en) | 2012-05-23 |
SG178044A1 (en) | 2012-03-29 |
NL2005102A (en) | 2011-01-18 |
EA025767B1 (ru) | 2017-01-30 |
AU2010272311A8 (en) | 2016-07-21 |
CA2768275C (en) | 2018-02-13 |
LU91786B1 (fr) | 2011-06-02 |
EA201200153A1 (ru) | 2012-07-30 |
BR112012000804B1 (pt) | 2021-03-30 |
AT13208U1 (de) | 2013-08-15 |
ES2886335T3 (es) | 2021-12-17 |
AU2010272311B2 (en) | 2016-02-11 |
KR20120070560A (ko) | 2012-06-29 |
AU2010272311A1 (en) | 2012-02-02 |
CA2768275A1 (en) | 2011-01-20 |
NL2005102C2 (en) | 2011-05-17 |
EP2453873B1 (en) | 2021-06-30 |
KR20180012866A (ko) | 2018-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012000804B8 (pt) | composição seca para mistura com água, solução aquosa, kit e composição de dose unitária para mistura com água | |
IN2012DN00306A (pt) | ||
BR112014029754B1 (pt) | soluções de tensoativos que contêm n-metil-noleilglucaminas e n-metil-n-c12-c14 acilglucaminas e seu uso, processo para produzir composições cosméticas e composição | |
EA201001555A1 (ru) | Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17 | |
ECSP109917A (es) | Nuevos derivados de ácido azabifenilaminobenzoico | |
BRPI0911681B8 (pt) | composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro | |
BR112015008912A2 (pt) | composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso | |
BR112013001039A2 (pt) | método de limpeza dos cabelos | |
EA201001556A1 (ru) | Соединения, включающие противовоспалительный фармакофор, и способы их применения | |
BR112012022775A2 (pt) | composições para a lavagem, do cólon e métodos para a produção e utilização das mesmas | |
BR112015006426A2 (pt) | composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos | |
BR112013031471A2 (pt) | composição de revestimento e método para uso da composição de revestimento | |
CL2009000309A1 (es) | Derivados fluoroglicosidos aromaticos, composicion farmaceutica que contenga estos compuestos, procedimiento para prepararla y su uso en el tratamiento de la diabetes tipo 1 y 2. | |
BR112015005270A8 (pt) | composição para mistura com água, solução de limpeza de cólon, seus usos e seu kit. | |
EA201171216A1 (ru) | Фенилацетат l-орнитина и способы его получения | |
JP2011500711A5 (pt) | ||
ECSP11011082A (es) | Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos | |
BRPI0916069C1 (pt) | composto, usos de um composto, composição farmacêutica, composição cosmética e usos cosméticos de uma composição | |
BR112015004089A2 (pt) | micro-organismos e métodos para intensificar a disponibilidade de equivalentes de redução na presença de metanol e para produzir 1,4-butanodiol relacionado com os mesmos | |
EA201001288A1 (ru) | Лечение гипертонии 25-гидроксивитамином d3 | |
BR112014000843A2 (pt) | Uso de picosulfato para preparação de composição intestinal para o cálculo da duração de colonoscopia, composição intestinal e kit | |
BR112016000839A8 (pt) | composições compreendendo policlorossulfato de alumínio, seus processos de produção, embalagens e processo de tratamento de água | |
BR112016006064A2 (pt) | composição de pró-dentifrício, composição com base em glicerina, e, kit para terapia da mucosa oral | |
UY33417A (es) | Formulación que contiene acido azelaico con adición de pigmento | |
BR112012017994A2 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/03/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |